Though my primary focus is on gene transfer, I will occasionally wander into other areas of translational pharmaceutical research, including cell transfer (also sometimes called “cell therapy”), monoclonal antibodies, small-molecule drugs that target novel biological mechanisms, or large-molecule drugs.
These types of translational clinical research raise a similar cluster of issues– namely, high degrees of uncertainty, risk, scientific complexity, desperately ill volunteers, ambitious investigators, financial interests, and complicated intellectual property issues.
BibTeX
@Manual{stream2008-184,
title = {The Scope of this Blog},
journal = {STREAM research},
author = {Jonathan Kimmelman},
address = {Montreal, Canada},
date = 2008,
month = feb,
day = 14,
url = {http://www.translationalethics.com/2008/02/14/the-scope-of-this-blog/}
}
MLA
Jonathan Kimmelman. "The Scope of this Blog" Web blog post. STREAM research. 14 Feb 2008. Web. 08 May 2024. <http://www.translationalethics.com/2008/02/14/the-scope-of-this-blog/>
APA
Jonathan Kimmelman. (2008, Feb 14). The Scope of this Blog [Web log post]. Retrieved from http://www.translationalethics.com/2008/02/14/the-scope-of-this-blog/
Leave a Reply